Unique Wealth Strategies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
3,733
-32
-0.8% -$11.9K 0.52% 36
2026
Q1
$1.1M Buy
3,765
+93
+3% +$30.6K 0.45% 56
2025
Q4
$1.29M Buy
3,672
+165
+5% +$55.8K 0.5% 45
2025
Q3
$1.13M Sell
3,507
-1,113
-24% -$346K 0.44% 56
2025
Q2
$1.8M Buy
4,620
+170
+4% +$68.4K 0.75% 28
2025
Q1
$1.94M Buy
4,450
+124
+3% +$49.8K 0.88% 26
2024
Q4
$1.6M Sell
4,326
-866
-17% -$362K 0.69% 33
2024
Q3
$2.7M Sell
5,192
-10
-0.2% -$5.34K 1.14% 19
2024
Q2
$2.7M Hold
5,202
1.26% 15
2024
Q1
$2.7M Buy
5,202
+73
+1% +$36.3K 1.32% 15
2023
Q4
$2.42M Buy
+5,129
New +$2.37M 1.61% 15

Other funds holding ELV

Unique Wealth Strategies's ELV Position: Q2 2026 in Review

Unique Wealth Strategies reduced its Elevance Health (ELV) stake by 0.85% in Q2 2026, selling an estimated $11.9K and leaving 3,733 shares worth $1.44M. The position accounts for 0.52% of the portfolio, ranked #36.

Unique Wealth Strategies first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.7M in Q3 2024. 222 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Unique Wealth Strategies held 3,733 shares of Elevance Health worth $1.44M as of Q2 2026.
  • Unique Wealth Strategies sold 32 Elevance Health shares in Q2 2026, an estimated $11.9K.
  • Elevance Health made up 0.52% of Unique Wealth Strategies's portfolio in Q2 2026, its #36 holding.
  • Unique Wealth Strategies first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Unique Wealth Strategies's Elevance Health position peaked at $2.7M in Q3 2024.
  • 222 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.